With the launch of its first…
With the launch of its first direct-to-patient program, Genentech is [...]
With the launch of its first direct-to-patient program, Genentech is [...]
A Keytruda-based regimen has shown a statistically significant overall survival [...]
In separate announcements on Wednesday, a pair of agencies shared [...]
With sales of potential blockbuster Lokelma scaling up, AstraZeneca is [...]
Just a few months after surfacing at Orca Bio following [...]
The positive readout could move Tukysa, which has been used [...]
With two Trump administration drug pricing deals in the books [...]
The FDA has tagged Novo Nordisk’s newly acquired manufacturing facility [...]
President Donald Trump has been pressuring top drugmakers to get [...]
The 2025 edition of Time’s annual “best inventions” list saw [...]